LMN-301
/ Lumen Bio
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
April 29, 2024
A Study to Determine the Tolerability of Intranasal LMN-301
(clinicaltrials.gov)
- P1 | N=35 | Completed | Sponsor: Lumen Bioscience, Inc. | Recruiting ➔ Completed
Trial completion • Infectious Disease • Novel Coronavirus Disease
October 04, 2023
A Study to Determine the Tolerability of Intranasal LMN-301
(clinicaltrials.gov)
- P1 | N=35 | Recruiting | Sponsor: Lumen Bioscience, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Novel Coronavirus Disease
September 11, 2023
A Study to Determine the Tolerability of Intranasal LMN-301
(clinicaltrials.gov)
- P1 | N=35 | Not yet recruiting | Sponsor: Lumen Bioscience, Inc.
New P1 trial • Infectious Disease • Novel Coronavirus Disease
1 to 3
Of
3
Go to page
1